genomics

By Laura Lovett May 16, 2018
DNA, health records, and blood test results are not only intimately personal, they are also a valuable asset to researchers. Recently a smattering of companies have been working to create a market for people to share and sell their personal data to researchers and healthcare players. Those efforts are going one step further, as two growing names in the health data and blockchain industry are...
By Bernie Monegain March 1, 2018
Helix has closed a $200 million financing round and said it plans to expand its personal genomics marketplace to accelerate consumer adoption of genomics. The San Carlos, California-based startup launched the Helix marketplace in July 2017 to collects and sequence a DNA sample once, and then store and protects a customer’s data so they can access additional DNA-powered products and services from...
By Heather Mack March 15, 2017
Seattle-based venture capital firm Biomatics Capital, which focuses on companies innovating around healthcare and technology, has closed its initiatory fund of $200 million. This exceeds the firm’s target of $150 million and spans a range of investors including individuals, family offices and institutions. Biomatics is particularly interested in genomics and digital health, and will use this fund...
By Jack McCarthy March 13, 2017
The importance of genomic and patient-generated data will increase dramatically in the next five years as healthcare managers gain control of big data to develop precision medicine. Forty percent of respondents to a new survey, in fact, said genomic data will become one of the most useful data sources in five years, up from just 17 percent today. And 40 percent said patient-generated data will be...
By Heather Mack January 5, 2017
Online network PatientsLikeMe, which serves as an information, support and study recruitment source for people living with chronic conditions, has secured $100 million in new funding, largely from a new partnership with health data and genomics company iCarbonX. Existing investor Invus also contributed to the funding round, which is still open. “This partnership is very exciting, as it...
By Jonah Comstock January 4, 2017
According to Rock Health's new end-of-the-year funding report, total digital health funding was down to $4.2 billion, an 8 percent drop from 2015's total of $4.6 billion. But even though less money was infused into the industry, 8 percent more companies received funding: 296 versus 273 last year, a record number of companies funded. Interestingly, nearly 20 percent of the funding was wrapped up...
By Heather Mack November 23, 2016
More than a decade ago, when most people were still using not-so-smart mobile phones, the first human genome was sequenced. It cost $3 billion. In the time it took for smartphones to become the essential consumer technology, DNA sequencing rapidly evolved from a costly, uncommonly used process into a quick, reliable, relatively cheap and widely used predictive tool to give insight on disease risk...
By Jonah Comstock November 25, 2013
23andMe's app. In a public letter dated November 22, the Food and Drug Administration has instructed personal genome startup 23andMe to immediately stop selling its testing service until the offering receives de novo 510(k) clearance. Regulatory Focus first spotted the letter. "[M]onths after you submitted your 510(k)s and more than 5 years after you began marketing, you still had not...
By Jonah Comstock March 19, 2013
UC Irvine researcher Gene Tsudik (Photo by Steve Zylius) A team led by University of California-Irvine researchers has developed what's been called an Android-based smartphone paternity test. The app would allow two people, if they had access to their digitized genomes, to run a paternity test comparing their genomes, determine how closely related they are, and even scan their genome for...
By Brian Dolan October 14, 2009
At the Body Computing Conference last week in Los Angeles, the Food and Drug Association's Brian Fitzgerald weighed in on a big question: Who owns your health data? According to a report in Fast Company, the typical answer most consumers would provide is "my body, my data." Fitzgerald, however, had an insightful and perhaps troubling reply. It made for a true regulatory monkey wrench: "These are...

Editor's Pick